Emma Guttman-Yassky ¹ , Lila Bahadori ² , Laura Brooks ³ , Ken L Clark ³ , Hanna Grindebacke ⁴ , Calvin N Ho ⁵ , Rohit Katial ^6,7 , Tuyet-Hang Pham ⁸ , Claire Walton ³ , Catherine J Datto ² & on behalf of the HILLIER study investigators

1 Icahn School of Medicine at Mount Sinai, New York, NY, USA
2 Late Stage Development, Respiratory & Immunology, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, MD, USA
3 Late Stage Development, Respiratory & Immunology, BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK
4 Late Stage Development, Respiratory & Immunology, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden
5 Patient Centered Science, BioPharmaceuticals Medical, AstraZeneca, Gaithersburg, MD, USA
6 BioPharmaceuticals Medical, AstraZeneca, Gaithersburg, MD, USA
7 National Jewish Health, Denver, CO, USA
8 Translational Science & Experimental Medicine, Early Respiratory & Immunology, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, MD, USA

Search | Advanced search